ORIC Pharmaceuticals, Inc. (ORIC) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Join SI Premium – FREE
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart shares fall despite earnings beat
- Advance Auto Parts falls on revenue miss, weak guidance
- Zoetis Inc. (ZTS) PT Lowered to $80 at Stifel as Key Franchise Price Realization Decelerates
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
